This topic contains a solution. Click here to go to the answer

Author Question: A patient is being discharged to his home on enoxaparin (Lovenox) injections for treatment of deep ... (Read 94 times)

mia

  • Hero Member
  • *****
  • Posts: 564
A patient is being discharged to his home on enoxaparin (Lovenox) injections for treatment of deep vein thrombosis (DVT). Which of the following statements made by the patient indicates a need for further discharge teaching by the nurse?
 
  a. I will inject the enoxaparin into the fatty tissue of my abdomen.
  b. I hate needles, but I know enoxaparin doesn't come in pill form.
  c. I will need to go to my doctor's office each day to have my blood drawn to see whether enoxaparin is working.
  d. I will call my physician immediately if I experience any uncontrollable bleeding while on enoxaparin.

Question 2

A patient applies a transdermal nitroglycerin patch at 0900. What additional instruction should be provided by the nurse regarding the patch?
 
  a. Leave the patch in place until the following morning, when a new patch will be applied.
  b. Apply an additional patch if breakthrough anginal pain occurs.
  c. Remove the patch at 9 PM.
  d. Note the location of the patch, so that it can be reapplied in the same location to enhance absorption.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

14vl19

  • Sr. Member
  • ****
  • Posts: 310
Answer to Question 1

ANS: C
The half-life of a low-molecular-weight (LMW) heparin, such as enoxaparin, is up to six times longer than that of unfractionated heparin. Less binding to macrophages and slower clearance by the liver are also factors. Because of enoxaparin's increased bioavailability, the plasma levels of the drug are highly predictable. As a result, it can be given on a fixed schedule with no need for routine monitoring of coagulation.
Enoxaparin is administered subcutaneously (into fatty tissue), and the abdomen is a correct injection site.
LMW heparins, such as enoxaparin, are available only for subcutaneous injection.
Bleeding is the major adverse effect and should be reported if it does not cease.

Answer to Question 2

ANS: C
A daily patch free interval of 10 to 12 hours is recommended. This can be accomplished by applying a new patch each morning, leaving it in place for 12 to14 hours, and then removing it in the evening.
A daily patch free interval of 10 to 12 hours is recommended. This can be accomplished by applying a new patch each morning, leaving it in place for 12 to14 hours, and then removing it in the evening.
An additional patch is never indicated, because hypotension may occur.
Patches should be rotated to different areas to prevent irritation and skin breakdown.




mia

  • Member
  • Posts: 564
Reply 2 on: Jul 23, 2018
:D TYSM


cpetit11

  • Member
  • Posts: 321
Reply 3 on: Yesterday
Excellent

 

Did you know?

Only 12 hours after an egg cell is fertilized by a sperm cell, the egg cell starts to divide. As it continues to divide, it moves along the fallopian tube toward the uterus at about 1 inch per day.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

Hypertension is a silent killer because it is deadly and has no significant early symptoms. The danger from hypertension is the extra load on the heart, which can lead to hypertensive heart disease and kidney damage. This occurs without any major symptoms until the high blood pressure becomes extreme. Regular blood pressure checks are an important method of catching hypertension before it can kill you.

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library